查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600098

心臟衰竭POC 和 LOC 设备市场：按设备类型、测试类型、技术、应用划分 - 2025-2030 年全球预测

Heart Failure POC & LOC Devices Market by Device Type (Lab-on-a-Chip (LOC) Devices, Point-of-Care (POC) Devices), Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing), Technology, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，心臟衰竭POC和LOC设备市场价值为9613万美元，预计到2024年将达到1.0887亿美元，复合年增长率为14.45%，到2030年将达到2.4737亿美元。

心臟衰竭护理点 (POC) 和晶片实验室 (LOC) 设备包括专为早期检测而设计的手持式和行动装置，可在患者所在地进行快速、准确的诊断，这彻底改变了心臟护理。这些技术的范围涵盖医院、诊所和居家医疗，重点是易用性和及时诊断，这对于有效的心臟衰竭管理至关重要。由于人口老化、生活方式的改变及其带来的巨大医疗负担，心臟病的盛行率不断增加，因此对 POC 和 LOC 设备的需求产生了。 POC 和 LOC 设备的应用扩展到各种环境，有助于即时介入和持续病患监测。最终用途范围包括医院、诊断实验室和个人化医疗，服务于都市区和农村地区。该市场的关键成长要素包括技术进步、医疗保健意识的提高以及对可携式诊断解决方案不断增长的需求。人工智慧和物联网的集合成为先进的诊断能力铺平了道路，并代表了巨大的成长机会。公司可以透过投资人工智慧驱动的分析和生物感测技术来抓住这些机会，以提高其设备的效率和可用性。然而，高昂的开发成本、监管条件和有限的报销环境等障碍构成了重大障碍。他们还必须解决当前技术限制和资料安全问题等限制。为了推动成长，微型感测器、增强资料整合和即时分析等技术创新是有前景的领域。对低成本製造技术的进一步研究可以扩大可及性，降低价格敏感度并开拓新市场。心臟衰竭POC和市场动态市场是一个动态市场，其特征是技术快速发展和激烈竞争。全面了解监管途径、促进合作以及注重以患者为中心的设计对于利用新机会和克服挑战至关重要。

主要市场统计
基准年[2023] 9613万美元
预测年份 [2024] 10887万美元
预测年份 [2030] 2.4737亿美元
复合年增长率（%） 14.45%

市场动态：针对快速发展的心臟衰竭POC 和 LOC 设备市场揭示的关键市场见解

供需的动态交互作用正在改变心臟衰竭POC 和 LOC 设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对疾病早期诊断的需求日益增加，以降低医疗费用
    • 加大力度开发带有感测器和其他配件的一次性低成本 LOC 设备
    • 政府更多地采用 POC 和 LOC 设备，以缓解不断增长的医疗保健支出
  • 市场限制因素
    • 对于具有执行多项测试的试剂盒的 POC 设备缺乏标准报销
  • 市场机会
    • 技术进步增加了新型生物标记鑑定的研究活动
    • 用于分析 LOC 测定资料以进行治疗监测的预测建模技术的新进展
  • 市场挑战
    • 居民的可及性和意识下降

波特五力：驾驭心臟衰竭POC 和 LOC 设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟衰竭POC 和 LOC 设备市场的外部影响

外部宏观环境因素在塑造心臟衰竭POC 和 LOC 设备市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心臟衰竭POC 和 LOC 设备市场的竞争格局

对心臟衰竭POC 和 LOC 设备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟衰竭POC 和 LOC 设备市场供应商的绩效评估

FPNV定位矩阵是评估心臟衰竭POC和LOC设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心臟衰竭POC 和 LOC 设备市场的成功之路

心臟衰竭POC 和 LOC 设备市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 为了降低医疗成本，对疾病早期诊断的需求不断增加。
      • 开发具有感测器和其他配件的一次性低成本 LOC 设备
      • 政府越来越多地采用 POC 和 LOC 设备，以缓解不断上涨的医疗成本
    • 抑制因素
      • 对于具有执行多项测试的试剂盒的 POC 设备没有标准报销
    • 机会
      • 促进识别新生物标记的研究工作的技术进步
      • 用于分析 LOC 测定资料以进行治疗监测的预测建模技术的新进展
    • 任务
      • 居民的可及性和意识下降
  • 市场区隔分析
    • 设备类型：由于易于使用，照护现场设备的使用正在各种环境中扩展。
    • 应用：为医院提供全面、先进的医疗保健解决方案
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章心臟衰竭POC 和 LOC 设备市场（按设备类型）

  • 实验室晶片(LOC) 设备
  • 照护现场(POC) 设备

第 7 章按测试类型分類的心臟衰竭POC 和 LOC 设备市场

  • 基因组测试
  • 代谢体学测试
  • 蛋白质体测试

第 8 章心臟衰竭POC 和 LOC 设备市场：依技术分类

  • 电化学感测
  • 微流体
  • 光学感

第 9 章心臟衰竭POC 和 LOC 设备市场：按应用分类

  • 辅助生活医疗设施
  • 诊所
  • 房子
  • 医院
  • 实验室

第10章美洲心臟衰竭POC和LOC设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区心臟衰竭POC和LOC设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲心臟衰竭POC和LOC设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 罗氏诊断印度公司推出 NT-proBNP 检测，用于糖尿病患者心臟衰竭的早期检测
    • FDA核准Eko Health 的人工智慧听诊器能够快速侦测低射血分数，增强心臟衰竭的早期诊断
    • 罗氏以 3.5 亿美元收购 LumiraDx照护现场技术，旨在扩大去分散式检查产品组合
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioTelemetry, Inc. by Royal Philips
  • Boditech Med Inc.
  • Danaher Corporation
  • Eko Health, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Jant Pharmacal Corporation
  • Johari Digital India Limited
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Lupin Limited
  • Masimo Corporation
  • Medtronic PLC
  • Novartis AG
  • Quidel Corporation
  • Sanner GmbH
  • Siemens Healthineers AG
  • Trinity Biotech PLC
  • uFluidix Inc.
Product Code: MRR-CA17E905EA91

The Heart Failure POC & LOC Devices Market was valued at USD 96.13 million in 2023, expected to reach USD 108.87 million in 2024, and is projected to grow at a CAGR of 14.45%, to USD 247.37 million by 2030.

Heart Failure Point-of-Care (POC) and Lab-on-Chip (LOC) devices have revolutionized cardiac care by enabling rapid and accurate diagnosis at the patient's location, encompassing handheld and portable devices designed for early detection. The scope of these technologies spans hospitals, clinics, and home care settings, emphasizing ease of use and timely diagnosis, which are crucial for effective heart failure management. The necessity for POC and LOC devices arises from the increasing prevalence of heart ailments driven by aging populations, lifestyle changes, and the significant healthcare burden they present. Their applications extend across various settings, facilitating immediate intervention and ongoing patient monitoring. The end-use scope includes hospitals, diagnostic laboratories, and personalized care, serving urban and rural communities alike. Key growth factors for this market include technological advancements, rising healthcare awareness, and increasing demand for portable diagnostic solutions. The integration of AI and IoT is paving the way for advanced diagnostic capabilities, marking significant growth opportunities. Companies could seize these opportunities by investing in AI-powered analytics and bio-sensing technologies to enhance device efficiency and user-friendliness. However, barriers such as high development costs, regulatory challenges, and limited reimbursement landscapes pose significant obstacles. Limitations like current technological constraints and data security concerns also need addressing. To foster growth, innovation in miniaturized sensors, enhanced data integration, and real-time analytics are promising areas. Further research in low-cost manufacturing techniques could broaden accessibility and reduce price sensitivity, unlocking new markets. The market for heart failure POC and LOC devices is dynamic, characterized by rapid technological evolution and competitive intensity. A thorough understanding of regulatory pathways, fostering collaborations, and a focus on patient-centered design will be pivotal in capitalizing on emerging opportunities and steering through challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 96.13 million
Estimated Year [2024] USD 108.87 million
Forecast Year [2030] USD 247.37 million
CAGR (%) 14.45%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Failure POC & LOC Devices Market

The Heart Failure POC & LOC Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for early diagnosis of diseases to reduce healthcare costs
    • Growing development of disposable and low-cost LOC devices with sensors and other accessories
    • Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
  • Market Restraints
    • Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
  • Market Opportunities
    • Advancements in technology to increase research activities for the identification of novel biomarkers
    • Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
  • Market Challenges
    • Reduced accessibility and awareness among the population

Porter's Five Forces: A Strategic Tool for Navigating the Heart Failure POC & LOC Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Failure POC & LOC Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Failure POC & LOC Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Failure POC & LOC Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Failure POC & LOC Devices Market

A detailed market share analysis in the Heart Failure POC & LOC Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Failure POC & LOC Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Failure POC & LOC Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Failure POC & LOC Devices Market

A strategic analysis of the Heart Failure POC & LOC Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Failure POC & LOC Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories Inc., AstraZeneca PLC, Becton, Dickinson and Company, bioMerieux SA, BioTelemetry, Inc. by Royal Philips, Boditech Med Inc., Danaher Corporation, Eko Health, Inc., F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Johari Digital India Limited, Lepu Medical Technology(Beijing)Co.,Ltd., Lupin Limited, Masimo Corporation, Medtronic PLC, Novartis AG, Quidel Corporation, Sanner GmbH, Siemens Healthineers AG, Trinity Biotech PLC, and uFluidix Inc..

Market Segmentation & Coverage

This research report categorizes the Heart Failure POC & LOC Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Lab-on-a-Chip (LOC) Devices and Point-of-Care (POC) Devices.
  • Based on Test Type, market is studied across Genomic Testing, Metabolomic Testing, and Proteomic Testing.
  • Based on Technology, market is studied across Electrochemical Sensing, Microfluidics, and Optical Sensing.
  • Based on Application, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratory.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for early diagnosis of diseases to reduce healthcare costs
      • 5.1.1.2. Growing development of disposable and low-cost LOC devices with sensors and other accessories
      • 5.1.1.3. Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology to increase research activities for the identification of novel biomarkers
      • 5.1.3.2. Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Reduced accessibility and awareness among the population
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Expanding usage of point-of-care devices in diverse settings owing to their user-friendliness
    • 5.2.2. Application: Provision of comprehensive, advanced healthcare solutions in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Heart Failure POC & LOC Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Lab-on-a-Chip (LOC) Devices
  • 6.3. Point-of-Care (POC) Devices

7. Heart Failure POC & LOC Devices Market, by Test Type

  • 7.1. Introduction
  • 7.2. Genomic Testing
  • 7.3. Metabolomic Testing
  • 7.4. Proteomic Testing

8. Heart Failure POC & LOC Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Electrochemical Sensing
  • 8.3. Microfluidics
  • 8.4. Optical Sensing

9. Heart Failure POC & LOC Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Assisted Living Healthcare Facilities
  • 9.3. Clinics
  • 9.4. Home
  • 9.5. Hospitals
  • 9.6. Laboratory

10. Americas Heart Failure POC & LOC Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Heart Failure POC & LOC Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Roche Diagnostics India Launches NT-proBNP Test for Early Detection of Heart Failure in Diabetes Patients
    • 13.3.2. FDA Clears Eko Health's AI-Powered Stethoscope for Rapid Low Ejection Fraction Detection, Enhancing Early Heart Failure Diagnosis
    • 13.3.3. Roche to Acquire LumiraDx's Point-of-Care Technology in a USD 350 Million Deal, Aiming to Expand Decentralized Testing Portfolio
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories Inc.
  • 3. AstraZeneca PLC
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. BioTelemetry, Inc. by Royal Philips
  • 7. Boditech Med Inc.
  • 8. Danaher Corporation
  • 9. Eko Health, Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Jant Pharmacal Corporation
  • 12. Johari Digital India Limited
  • 13. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 14. Lupin Limited
  • 15. Masimo Corporation
  • 16. Medtronic PLC
  • 17. Novartis AG
  • 18. Quidel Corporation
  • 19. Sanner GmbH
  • 20. Siemens Healthineers AG
  • 21. Trinity Biotech PLC
  • 22. uFluidix Inc.

LIST OF FIGURES

  • FIGURE 1. HEART FAILURE POC & LOC DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEART FAILURE POC & LOC DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEART FAILURE POC & LOC DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LAB-ON-A-CHIP (LOC) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY POINT-OF-CARE (POC) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY OPTICAL SENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2023